NKP-1339 is the first-in-class ruthenium-based anticancer drug in clinical development against solid cancer and has recently been studied successfully in a phase I clinical trial.
Molecular Weight:
502.14
CAS Number:
[197723-00-5]
Formula:
C14H12Cl4N4NaRu
* VAT and and shipping costs not included. Errors and price changes excepted